Table 5:

Echocardiographic follow-up

VariableBV (n = 23)BI (n = 21)P-value
Follow-up months43.0 ± 15.88.4 ± 4.2<0.001
EF (%)55.0 (50.3–55.0)50.0 (44.0–55.0)0.12
Aortic regurgitation
 None/trace21 (91.3)16 (76.2)0.23
 Mild2 (8.7)5 (23.8)0.23
 Moderate0 (0)0 (0)1.00
 Severe0 (0)0 (0)1.00
Pmax (mmHg)18.0 (16.0–23.3)19.0 (14.0–24.0)0.87
 25 mm valve19.5 (11.0–29.8)15.5 (13.5–20.5)0.76
 27 mm valve16.0 (16.0–22.0)22.0 (19.6–24.0)0.10
Vmax (m/s)2.10 (1.99–2.60)2.20 (1.80–2.40)0.82
 25 mm valve2.20 (1.63–3.13)1.96 (1.83–2.31)0.76
 27 mm valve2.00 (1.99–2.27)2.35 (2.20–2.40)0.07
MPG (mmHg)11.0 (8.3–14.8)11.5 (9.0–13.0)0.82
 25 mm valve12.0 (9.5–18.0)9.5 (8.3–12.3)0.41
 27 mm valve10.0 (8.0–14.75)12.0 (12.0–13.0)0.42
EOA (cm2)1.85 (1.55–2.21)1.80 (1.64–1.83)0.24
 25 mm valve1.80 (1.25–2.50)1.85 (1.69–1.98)0.78
 27 mm valve2.00 (1.60–2.20)1.70 (1.63–1.80)0.20
VariableBV (n = 23)BI (n = 21)P-value
Follow-up months43.0 ± 15.88.4 ± 4.2<0.001
EF (%)55.0 (50.3–55.0)50.0 (44.0–55.0)0.12
Aortic regurgitation
 None/trace21 (91.3)16 (76.2)0.23
 Mild2 (8.7)5 (23.8)0.23
 Moderate0 (0)0 (0)1.00
 Severe0 (0)0 (0)1.00
Pmax (mmHg)18.0 (16.0–23.3)19.0 (14.0–24.0)0.87
 25 mm valve19.5 (11.0–29.8)15.5 (13.5–20.5)0.76
 27 mm valve16.0 (16.0–22.0)22.0 (19.6–24.0)0.10
Vmax (m/s)2.10 (1.99–2.60)2.20 (1.80–2.40)0.82
 25 mm valve2.20 (1.63–3.13)1.96 (1.83–2.31)0.76
 27 mm valve2.00 (1.99–2.27)2.35 (2.20–2.40)0.07
MPG (mmHg)11.0 (8.3–14.8)11.5 (9.0–13.0)0.82
 25 mm valve12.0 (9.5–18.0)9.5 (8.3–12.3)0.41
 27 mm valve10.0 (8.0–14.75)12.0 (12.0–13.0)0.42
EOA (cm2)1.85 (1.55–2.21)1.80 (1.64–1.83)0.24
 25 mm valve1.80 (1.25–2.50)1.85 (1.69–1.98)0.78
 27 mm valve2.00 (1.60–2.20)1.70 (1.63–1.80)0.20

Data are presented as mean ± SD, median (25th–75th percentiles) or number (%).

EF: ejection fraction; Pmax: peak pressure gradient; Vmax: peak aortic jet velocity; MPG: mean pressure gradient; EOA: effective orifice area; BV: BioValsalva; BI: BioIntegral; SD: standard deviation.

Table 5:

Echocardiographic follow-up

VariableBV (n = 23)BI (n = 21)P-value
Follow-up months43.0 ± 15.88.4 ± 4.2<0.001
EF (%)55.0 (50.3–55.0)50.0 (44.0–55.0)0.12
Aortic regurgitation
 None/trace21 (91.3)16 (76.2)0.23
 Mild2 (8.7)5 (23.8)0.23
 Moderate0 (0)0 (0)1.00
 Severe0 (0)0 (0)1.00
Pmax (mmHg)18.0 (16.0–23.3)19.0 (14.0–24.0)0.87
 25 mm valve19.5 (11.0–29.8)15.5 (13.5–20.5)0.76
 27 mm valve16.0 (16.0–22.0)22.0 (19.6–24.0)0.10
Vmax (m/s)2.10 (1.99–2.60)2.20 (1.80–2.40)0.82
 25 mm valve2.20 (1.63–3.13)1.96 (1.83–2.31)0.76
 27 mm valve2.00 (1.99–2.27)2.35 (2.20–2.40)0.07
MPG (mmHg)11.0 (8.3–14.8)11.5 (9.0–13.0)0.82
 25 mm valve12.0 (9.5–18.0)9.5 (8.3–12.3)0.41
 27 mm valve10.0 (8.0–14.75)12.0 (12.0–13.0)0.42
EOA (cm2)1.85 (1.55–2.21)1.80 (1.64–1.83)0.24
 25 mm valve1.80 (1.25–2.50)1.85 (1.69–1.98)0.78
 27 mm valve2.00 (1.60–2.20)1.70 (1.63–1.80)0.20
VariableBV (n = 23)BI (n = 21)P-value
Follow-up months43.0 ± 15.88.4 ± 4.2<0.001
EF (%)55.0 (50.3–55.0)50.0 (44.0–55.0)0.12
Aortic regurgitation
 None/trace21 (91.3)16 (76.2)0.23
 Mild2 (8.7)5 (23.8)0.23
 Moderate0 (0)0 (0)1.00
 Severe0 (0)0 (0)1.00
Pmax (mmHg)18.0 (16.0–23.3)19.0 (14.0–24.0)0.87
 25 mm valve19.5 (11.0–29.8)15.5 (13.5–20.5)0.76
 27 mm valve16.0 (16.0–22.0)22.0 (19.6–24.0)0.10
Vmax (m/s)2.10 (1.99–2.60)2.20 (1.80–2.40)0.82
 25 mm valve2.20 (1.63–3.13)1.96 (1.83–2.31)0.76
 27 mm valve2.00 (1.99–2.27)2.35 (2.20–2.40)0.07
MPG (mmHg)11.0 (8.3–14.8)11.5 (9.0–13.0)0.82
 25 mm valve12.0 (9.5–18.0)9.5 (8.3–12.3)0.41
 27 mm valve10.0 (8.0–14.75)12.0 (12.0–13.0)0.42
EOA (cm2)1.85 (1.55–2.21)1.80 (1.64–1.83)0.24
 25 mm valve1.80 (1.25–2.50)1.85 (1.69–1.98)0.78
 27 mm valve2.00 (1.60–2.20)1.70 (1.63–1.80)0.20

Data are presented as mean ± SD, median (25th–75th percentiles) or number (%).

EF: ejection fraction; Pmax: peak pressure gradient; Vmax: peak aortic jet velocity; MPG: mean pressure gradient; EOA: effective orifice area; BV: BioValsalva; BI: BioIntegral; SD: standard deviation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close